CURE’s rare cancers page is a go-to resource for oncology news and updates in the world of rare cancers Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in rare cancers.
Patients with neuroendocrine tumors have more treatment options than ever before.
September 12th 2025, 5:00pm
When I think about standing up to cancer, I cannot separate the words from my own story.
August 13th 2025, 5:00pm
When I was diagnosed with peritoneal mesothelioma at 21 years old, the doctors gave me 18 months to live; that was 18 years ago.
August 12th 2025, 4:00pm
I was facing rare mesothelioma alone at 21 years old, but sharing my story connected me to a community that offers hope and strength to keep fighting.
August 9th 2025, 6:00pm
Support and research for epithelioid hemangioendothelioma are growing, with the EHE Foundation helping connect patients to expert care and resources.
August 7th 2025, 5:00pm
I survived peritoneal mesothelioma thanks to the love, prayers, and support of family, friends, and strangers who reminded me I was never alone.
August 4th 2025, 4:00pm
Treatment options for patients with epithelioid hemangioendothelioma vary dependent on disease status, but more therapies are under investigation.
August 1st 2025, 5:00pm
Dr. Michael Wagner covers the basics of epithelioid hemangioendothelioma, a rare vascular cancer, spanning symptoms, diagnosis, treatment options and more.
July 2nd 2025, 6:00pm
Tamron Little was diagnosed with peritoneal mesothelioma in 2007 as a 21-year-old new mother. Catch up on Tamron's blogs here!
June 20th 2025, 5:00pm
Surviving cancer wasn’t the end of my story; it was the start of redefining life, finding purpose and offering hope to those walking behind me.
June 18th 2025, 5:00pm
I finally felt like a survivor the day I heard my 18-month scans were clear, shifting from fear to faith and realizing I was not just surviving — I was thriving.
How to Access Support Resources for Rare Cancers
The Defining Moments of Support After Hearing ‘You Have Cancer’
Off-the-Shelf Immunotherapy May Offer Benefits in Kidney Cancer
Gleevec Associated With Long-Term Effectiveness in Treating GIST